• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 8, Issue 4
  3. Author

Online ISSN: 2515-8260

Volume8, Issue4

Role of vital parameters and biomarkers in predicting the outcome of patients in Covid ICU: A comparative study

    SouravBansal, Arghadip Das,Nikhat Fatima Mansoori, Irshan Ali Mohammed, Vinodh Boopalraj

European Journal of Molecular & Clinical Medicine, 2021, Volume 8, Issue 4, Pages 1159-1168

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Aim: The aim of the present study to compare the vital parameters and biomarkers in
predicting the outcome of patients in Covid ICU.
Methods: 200 patient were divided in to two groups, Group A of those who expired and
Group B of the survivors. The mean for each parameter was calculated and compared
among the two groups and based on which p value was calculated for each parameter
undertaken in clinical evaluation. Blood reports of investigations assessing the levels of
biomarkers like Procalcitonin (PCT), C- Reactive Protein (CRP), D-dimer, Ferritin,
Lactate dehydrogenase (LDH) and Interleukin-6 (IL-6) sent on first day and last day of
hospitalisation in covid ICU were collected for Group A (Expired) and Group B (Survived)
and master chart was prepared.
Results: The study population comprised of 200 confirmed Covid-19 cases, among which
those expired (Group A) were 103, and those who survived (Group B) were 97. The mean
age difference was statistically significant (p value = 0.003). The mean Heart Rate on day
of admission was statistically significant (p value = 0.005). The mean Heart Rate on last
day of hospitalisation difference was statistically significant (p value = 0.001). The
Median PCT levels along with along with its interquartile range in Group A (Expired)
versus Group B (Survivors) on day of admission the difference was statistically significant
(p value < 0.001). The Median Ferritin levels along with its interquartile range in Group A
(Expired) versus Group B (Survivors) on day of admission the difference was statistically
significant (p value < 0.0003). The Median Ferritin levels along with its interquartile range
in Group A (Expired) versus Group B (Survivors) on last day of hospitalisation the
difference was statistically significant (p value < 0.001).
Keywords:
    Covid pandemic intensive care unit
  • PDF (300 K)
  • XML
(2021). Role of vital parameters and biomarkers in predicting the outcome of patients in Covid ICU: A comparative study. European Journal of Molecular & Clinical Medicine, 8(4), 1159-1168.
SouravBansal, Arghadip Das,Nikhat Fatima Mansoori, Irshan Ali Mohammed, Vinodh Boopalraj. "Role of vital parameters and biomarkers in predicting the outcome of patients in Covid ICU: A comparative study". European Journal of Molecular & Clinical Medicine, 8, 4, 2021, 1159-1168.
(2021). 'Role of vital parameters and biomarkers in predicting the outcome of patients in Covid ICU: A comparative study', European Journal of Molecular & Clinical Medicine, 8(4), pp. 1159-1168.
Role of vital parameters and biomarkers in predicting the outcome of patients in Covid ICU: A comparative study. European Journal of Molecular & Clinical Medicine, 2021; 8(4): 1159-1168.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 236
  • PDF Download: 786
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus